Finance

Lists
Why is AARD down 7,74%?
Dive Deeper
AARD:NASDAQ
Aardvark Therapeutics Inc
0,92 $
-7,74%
(-0,077) 1D
20 նոյ, 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AARD...
Open
1,00 $
High
1,06 $
Low
0,90 $
Mkt. cap
20,20 մլն
Avg. vol.
1,22 մլն
Volume
241,08 հզր
52-wk high
16,60 $
52-wk low
0,90 $
EPS
-3,33 $
Shares outstanding
21,89 մլն
No. of employees
27
Open
1,00 $
High
1,06 $
Low
0,90 $
Mkt. cap
20,20 մլն
Avg. vol.
1,22 մլն
Volume
241,08 հզր
52-wk high
16,60 $
52-wk low
0,90 $
EPS
-3,33 $
Shares outstanding
21,89 մլն
No. of employees
27
News stories
From web sources and news partners
About Aardvark Therapeutics Inc
CEO-
Employees27
Founded2017
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 7 analysts giving stock ratings to AARD in the past 3 months
Sell
Buy
0
Hold
5
Sell
2
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AARD in the last 3 months.
Highest
Current 0,92 $
3,00 $ (+225,17%)
Average
2,20 $ (+138,46%)
Lowest
1,50 $ (+62,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Condulis
Stifel Nicolaus
Hold
Maintained
2,00 $
+116,8%
11/17/2026
Michael Ulz
Morgan Stanley
Sell
Maintained
3,00 $
+225,2%
11/13/2026
Brian Abrahams
RBC Capital
Hold
Maintained
2,50 $
+171%
11/13/2026
Christopher Raymond
Raymond James
Hold
Downgraded
-
-
11/04/2026
Leland Gershell
Oppenheimer
Hold
Downgraded
-
-
10/26/2026
Ram Selvaraju
H.C. Wainwright
Hold
Maintained
2,00 $
+116,8%
10/26/2026
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
1,50 $
+62,6%
10/23/2026
Jeet Mukherjee
BTIG
Hold
Maintained
-
-
08/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
08/12/2026
William Wood
B. Riley Securities
Buy
Maintained
7,00 $
+658,7%
05/15/2026
Tim Anderson
Bank of America Securities
Buy
Reiterated
18,00 $
+1 851%
05/08/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
45,00 $
+4 777,5%
03/02/2026
Last report
2026 թ. նոյ 13
Fiscal period
Q3 2026
-0,88 $ / -0,77 $
-14,29%miss
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,30 մլն
16,57 մլն
10,46 մլն
15,67 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,40 մլն
5,90 մլն
4,63 մլն
4,05 մլն
Operating expense
18,70 մլն
22,46 մլն
15,08 մլն
19,72 մլն
Total operating expenses
18,70 մլն
22,46 մլն
15,08 մլն
19,72 մլն
Operating income
-18,70 մլն
-22,46 մլն
-15,08 մլն
-19,72 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-17,60 մլն
-21,59 մլն
-14,39 մլն
-19,19 մլն
EBT excluding unusual items
-17,58 մլն
-21,58 մլն
-14,39 մլն
-19,18 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17,60 մլն
-21,59 մլն
-14,39 մլն
-19,19 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,81
-0,99
-0,66
-0,88
Interest and investment income
1,12 մլն
889,00 հզր
695,00 հզր
539,00 հզր
Interest expense
-
-
-
-
Net interest expenses
1,12 մլն
889,00 հզր
695,00 հզր
539,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-18,69 մլն
-22,45 մլն
-15,07 մլն
-19,71 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps